ArticleBMJ open2021

A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol.

Julia Spierings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.